LRG FUNDS PORTFOLIO
LRG Funds News
- August 24, 2010: LRG Capital Real Estate Fund Update- Q2 2010
- May 10, 2010: LRG Real Estate Partners Aquire Lease Option for Fair-Anselm Shopping Plaza
- May 4, 2010: LRG Capital Real Estate Partners Acquires Fair-Anselm Plaza in Fairfax, California
- May 3, 2010: LRG Capital Real Estate Partners Host Sold Out Commercial Real Estate Forum, Thursday April 29
- April 27, 2010: Larkspur investment firm has eye on Fairfax grocery site
- DIRECT TO ALL LRG FUNDS NEWS
LRG BayStar Capital Funds Portfolio
PORTFOLIO COMPANIES
Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:
Esperion Therapeutics, Inc. (Acquired by Pfizer in 2004, then was spun back out in 2008)
Esperion Therapeutics, Inc. is a company dedicated to discovering and producing new medicines to treat atherosclerosis, diabetes, obesity, stroke, and related metabolic disorders.
http://www.esperion.com/company/index.php
Genome Therapeutics Corporation
Genome Therapeutics is a biopharmaceutical company engaged in the discovery and development of pharmaceutical products for specialty markets.
Guilford Pharmaceuticals, Inc. (Merged in 2005 with MGi Pharma, Inc)
Guilford Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of novel products for the treatment of cancer and neurological diseases and conditions.
ILEX Oncology, Inc. (Acquired in 2006 by Genzyme Corp)
ILEX Oncology is a drug development company focused exclusively on the accelerated development of drugs for the prevention and treatment of cancer.
InterMune Pharmaceuticals, Inc. (ITMN)
InterMune is a biotechnology company dedicated to the development and commercialization of innovative products for the treatment of serious pulmonary, infectious and congenital diseases. http://www.intermune.com
